首页 / 专利分类库 / 有机化学 / 无环或碳环化合物 / 硫脲,即含下列基团NCSN或NCSN中的任何一个的化合物,其中的氮原子不属于硝基或亚硝基
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
101 PROCESS FOR THE PURIFICATION OF 1,4-BENZOQUINONE GUANYLHYDRAZONE THIOSEMICARBAZONE (AMBAZONE) UAA200604639 2004-09-15 UA78470C2 2007-03-15
The invention is relates to a process for the purification of 1,4-benzoquinone guanylhydrazone thiosemicarbazone (ambazone) in two steps. At the first step, it takes place the removal of sulfur from ambazone by maceration of ambazone in a non-polar solvent (benzene, n-hexane, toluene or xylene). At the second step, it takes place the recrystallization of ambazone from a mixture N,N-dimethylformamide and lower aliphatic alcohols (C1-C4) at temperatures between 50-80 DEGREE C.
102 2'-substituirani 1,1'-bifenil-2-karboksamidi, postopek za njihovo pripravo, njihova uporaba kot zdravilo, kot tudi farmacevtski pripravki, ki jih vsebujejo SI200030883 2000-09-19 SI1222163T1 2006-10-31 BRENDEL JOACHIM; SCHMIDT WOLFGANG; BELOW PETER
103 ADESAO CELULAR MEDIADA POR INIBIDORES DE ALFA4 PT99904115 1999-01-19 PT1049662E 2006-09-29 ILA SIRCAR; GUDMUNDSSON KRISTJAN S; RICHARD MARTIN
104 MEJORA AL PROCESO DE LIXIVIACION DE PLATA Y ORO CON SOLUCIONES DE TIOUREA. MXPA03002005 2003-03-07 MXPA03002005A 2004-09-09 LAPIDUS LAVINE GRETCHEN TERRI; LOPEZ ESCUTIA MARIA CONCEPCION; OROPEZA GUZMAN MERCEDES TERESITA
La presente invencion esta relacionada con la industria minera y de tratamiento de minerales. Especificamente se relaciona con una composicion de disolucion que permite el uso de tiourea. Especificamente, la patente se refiere a una disolucion que mejore tanto la velocidad de extraccion de plata, a partir de minerales su otros materiales que la contengan, mejorando la estabilidad del tiourea en la disolucion lixiviante. El invento consiste en una disolucion del lixiviacion que anterior o simultaneamente ha y asido sujeto a una electro-oxidacion controlada para producir DSFA que actua como una agente oxidante para las fases minerales que contiene el oro y la plata. En su modalidad preferida el DSFA se encuentra en una proporcion de10 a 30% de la tiourea total contenido en la disolucion.
105 NO960411 1996-01-31 NO315160B1 2003-07-21 ENGLERT HEINRICH; HARTUNG JENS; CRAUSE PETER; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
106 Substituted benzenesulfonylureas and -thioureas, processes for their preparation and a medicament containing thereof CZ43596 1996-02-14 CZ291793B6 2003-05-14 ENGLERT HEINRICH; GERLACH UWE; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
In the present invention there are disclosed benzenesulfonylureas or ?thioureas of the general formula I in which: R(1) represents hydrogen, alkyl having 1 to 7 carbon atoms or cycloalkyl having 3 to 7 carbon atoms; R(2) denotes hydrogen, fluorine, chlorine, alkyl having 1 to 6 carbon atoms, cycloalkyl containing 3 to 6 carbon atoms, a carbon chain with 1 to 8 carbon atoms in which 1 to 4 carbon atoms are replaced oxygen, nitrogen or sulfur; R(3) and R(4) represent each hydrogen alkyl having 1 to 12 carbon atoms, cycloalkyl having 3 to 10 carbon atoms, fluoroalkyl having 1 to 6 carbon atoms, fluoro cycloalkyl having 3 to 6 carbon atoms, or a carbon chains with 1 to 10 carbon atoms in which 1 to 4 carbon atoms are replaced by oxygen, nitrogen or sulfur; or R(3) and R(4) together form a (CHi2)i2-8 ring, in which one of the -CHi2- groups can be replaced by oxygen, nitrogen or sulfur; E represents oxygen or sulfur; X denotes oxygen or sulfur; Y represents [CR(5)R(5')]im, wherein R(5) and R(5') independently of one another represent hydrogen or alkyl having 1 or 2 carbon atoms; whereby the members of the [CR(5)R(5')]im group are identical or different; and m is 1, 2, 3 or 4, as well as a pharmaceutically acceptable salt thereof. These compounds exhibit effects on the cardiovascular system. Further described is also a process for preparing such compounds as well a medicament in which they are comprised.
107 Novel anti-adhesive compounds and uses thereof AU2002255704 2002-03-12 AU2002255704A1 2002-09-24 SMITH ROBERT D; ALBERTE RANDALL S
108 NOVEL SUBSTITUTED DERIVATIVES OF THIOPHENOSULPHONYL CARBAMIDE AND THIOPHENOSULPHONYL THIOCARBAMIDE, METHOD OF OBTAINING THEM, THEIR APPLICATION IN PRODUCTION OF PHARMACEUTICAL AGENTS AND PHARMACEUTICAL AGENT AS SUCH PL31253296 1996-01-29 PL183561B1 2002-06-28 ENGLERT HEINRICH; HARTUNG JENS; CRAUSE PETER; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
109 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation DE10030891 2000-06-23 DE10030891A1 2002-01-03 LEY JAKOB; JOHNCOCK WILLIAM; LANGNER ROLAND
The invention relates to 3,4-dihydroxybenzyl-substituted carbonic acid derivatives, to their production, and to their use as antioxidants or free-radical scavengers, especially in cosmetic and pharmaceutical preparations and in foodstuffs and stimulants, to protect cells and tissues from the harmful effects of radicals and reactive oxygen compounds that accelerate aging. The invention further relates to cosmetic and pharmaceutical preparations and to foodstuffs and stimulants that comprises the inventive 3,4-dihydroxybenzyl-substituted carbonic acid derivatives.
110 SUBSTITUTED BENZENESULFONYLUREAS AND -THIOUREAS, PROCESS FOR THEIR PREPARATION AND THE USE OF PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS, AS WELL AS MEDICAMENTS CONTAINING THEM HRP960076 1996-02-15 HRP960076B1 2001-12-31 ENGLERT HEINRICH; GERLACH UWE; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
111 BR9916041 1999-12-06 BR9916041A 2001-12-04 BLOOM JONATHAN DAVID; DIGRANDI MARTIN JOSEPH; GEORGEDUSHIN RUSSELL; LANG STANLEY ALBERT; O'HARA BRYAN MARK
112 SUBSTITUTED THIOPHENYLSULFONYLUREAS AND-THIOUREAS, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS OR DIAGNOSTICS AND MEDICAMENTS CONTAINING THEM IL11698096 1996-01-31 IL116980A 2001-06-14
113 Benzenesulfonyl substituted ureas and -thioureas, process for their preparation and use of pharmaceutical preparations based on these compounds as well as medicaments containing them. ES96101977 1996-02-12 ES2155546T3 2001-05-16 ENGLERT HEINRICH; GERLACH UWE; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
BENZOLSULFONILUREAS Y -TIOUREAS DE FORMULA I, DONDE R(1) ES HIDROGENO, ALQUILO CON 1, 2, 3, 4, 5, 6 O 7 ATOMOS DE C, CICLOALQUILO CON 3, 4, 5, 6 O 7 ATOMOS DE C; R(2) ES HIDROGENO, ALQUILO CON 1, 2, 3, 4, 5 O 6 ATOMOS DE C, ALCOXI CON CON 1, 2, 3, 4, 5 O 6 ATOMOS DE C, MERCAPTOALQUILO CON 1, 2, 3, 4, 5 O 6 ATOMOS DE C, CICLOALQUILO CON 3, 4, 5 O 6 ATOMOS DE C, Y OTRAS CADENAS DE C{SUB,1}-C{SUB,8}, EN LAS CUALES N ATOMOS DE C ESTAN SUSTITUIDOS POR HETEROATOMOS, PE O, N, S (N=1-4), F, CL; R(3) H, ALQUILO CON 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 O 12 ATOMOS DE C, CICLOALQUILO CON 3, 4, 5, 6, 7, 8, 9 O 10 ATOMOS DE C, FLUOROALQUILO CON 3, 4, 5 O 6 ATOMOS, O CADENAS DE C{SUB,1}C{SUB,10}, EN LAS CUALES N ATOMOS DE C ESTAN SUSTITUIDOS POR HETEROATOMOS, PE O, N, S (N=1, 2, 3 O 4); R(4) ES HIDROGENO, ALQUILO CON 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 O 12 ATOMOS DE C, CICLOALQUILO CON 3, 4, 5, 6, 7, 8, 9 O 10 ATOMOS DE C, FLUOROALQUILO CON 1, 2, 3, 4, 5 O 6 ATOMOS DE C, FLUOROCICLOALQUILO CON 3, 4, 5O 6 ATOMOS DE C, O CADENAS DE C{SUB,1}-C{SUB,10}, EN LAS CUALES N ATOMOS DE C ESTAN SUSTITUIDOS POR HETEROATOMOS, PE O, N, S (N=1, 2, 3 O 4); OR(3) YR(4) FORMAN JUNTOS UN ANILLO (CH{SUB,2}){SUB,2-8}, EN EL CUAL UNO O VARIOS GRUPOS CH{SUB,2} PUEDEN ESTAR SUSTITUIDOS POR HETEROATOMOS; E ES OXIGENO O AZUFRE; X ES OXIGENO O AZUFRE; Y ES [CR(5)R(5){SUP,''})]{SUB,M}; SIENDO R(5) YR(5{SUP,''}) INDEPENDIENTEMENTE UNO DE OTRO HIDROGENO O ALQUILO CON 1 O 2 ATOMOS DE C; DONDE LOS MIEMBROS DE [(CR(5)R(5{SUP,''})] PUEDEN SER IGUALES O DIFERENTES; YM ES 1, 2, 3 O 4. TAMBIEN SUS SALES FARMACEUTICAMENTE ACEPTABLES, TIENE EFECTOS MUY IMPORTANTES EN EL SISTEMA CARDIOVASCULAR.
114 SUBSTITUTED THIOPHENSULFONYLUREAS, METHOD OF THEIR SYNTHESIS AND DRUG RU96101797 1996-01-31 RU2164916C2 2001-04-10 KHAJNRIKH EHNGLERT; JENS KHARTUNG; PETER KRAUZE; DITER MANIA; KHAJNTS GEGELAJN; JOAKHIM KAJZER
organic chemistry, pharmacy. SUBSTANCE: invention describes novel substituted thophensulfonylureas of the general formula (I) where R(1) means hydrogen atom or alkyl with one or two carbon atoms; R(2) means hydrogen atom or alkyl with one or two carbon atoms; Y and Z are similar or different and mean halogen atom or alkoxy-group with one or two carbon atoms; X means oxygen or sulfur atom, or their physiologically acceptable salts. Compounds show effect on cardiovascular system. Invention describes method of their synthesis and medicinal agent also. EFFECT: new compounds indicated above, improved method of synthesis, valuable medicinal properties. 6 cl, 7 ex
115 SUBSTITUTED THIOPHENYL-SULFONYL-UREA- AND -THIOUREA DERIVATIVES PROCESS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HU9600218 1996-01-31 HU9600218A3 2000-03-28
116 Use of substituted thione compounds as nitric oxide synthase activators DE19830081 1998-07-06 DE19830081A1 2000-01-13 CLEMENT BERND
Use of diaminothiones as nitric oxide (NO) synthase activators is new. Use of diaminothione derivatives of formula (I) and their tautomers and salts, as nitric oxide (NO) synthase activators is new: R1-R4 = H or alkyl, aryl or heterocyclyl (saturated or unsaturated, and each optionally substituted); or R2 + R4 or R1 + R2 and/or R3 + R4 = a saturated or unsaturated, optionally substituted 3-8 membered ring. An Independent claim is also included for the use of compounds (I) for the production of a medicament for increasing NO concentrations.
117 BR9709952 1997-06-24 BR9709952A 1999-08-10 WIDDOWSON KATHERINE L
118 NO960628 1996-02-16 NO305795B1 1999-07-26 ENGLERT HEINRICH; GERLACH UWE; MANIA DIETER; GOEGELEIN HEINZ; KAISER JOACHIM
119 IL-8 RECEPTOR ANTAGONIST CZ425698 1997-06-24 CZ425698A3 1999-06-16 WIDDOWSON KATHERINE L
120 ANTAGONISTS OF IL-8 RECEPTORS PL33085097 1997-06-24 PL330850A1 1999-06-07 WIDDOWSON KATHERINE L
QQ群二维码
意见反馈